OpenEvidence will license clinical guidance from the Philadelphia-based American College of Physicians and published content from the college’s peer-reviewed journal, Annals of Internal Medicine.
The licensing agreement will integrate ACP content into OpenEvidence’s AI-powered clinical decision support platform. Physicians using the tool can draw on the college’s clinical recommendations and Annals research at the point of care, according to a Nov. 9 news release.
Miami-based OpenEvidence, which is free for verified U.S. clinicians, said the majority of U.S. physicians use the platform daily, on average.
ACP, the largest medical specialty organization in the U.S., has 163,000 members, including internal medicine physicians, subspecialists and medical students, in more than 172 countries. The college develops clinical guidelines, guidance statements, practice points and best practice advice.
Jan K. Carney, MD, president of ACP, said real-time access to the college’s guidance and Annals content can help physicians make better-informed clinical decisions and spend more time on patient care.
Internal medicine is now the largest specialty on OpenEvidence, said Travis Zack, MD, PhD, chief medical officer of OpenEvidence. Dr. Zack said a single internist’s clinic session can span heart failure treatment, thyroid nodules and drug interactions for patients on many medications. The deal means more answers will draw on evidence internists already trust, “with the citation right there to check,” Dr. Zack said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
